推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

ENDOCRINE-RELATED CANCER

2022年12月最新中科院JCR期刊分区表数据(升级版)已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ENDOCR-RELAT CA最新评论:杂志由 society for endocrinology 出版或管理。 issn号:(printed): 1351-0088 (electronic): 1479-6821 影响因子... (2013-04-02)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看:


ENDOCRINE-RELATED CANCER期刊基本信息Hello,您是该期刊的第24521位访客

基本信息 登录收藏
期刊名字ENDOCRINE-RELATED CANCERENDOCRINE-RELATED CANCER

ENDOCR-RELAT CANCER

LetPub评分
7.4
50人评分
我要评分

声誉
8.8

影响力
6.5

速度
7.0

期刊ISSN1351-0088
微信扫码收藏此期刊
2021-2022最新影响因子
(数据来源于搜索引擎)
5.900 点击查看影响因子趋势图
2021-2022自引率3.40%点击查看自引率趋势图
h-index 119
CiteScore
CiteScoreSJRSNIPCiteScore排名
9.901.4161.515
学科分区排名百分位
大类:Medicine
小类:Endocrinology, Diabetes and Metabolism
Q125 / 227
大类:Medicine
小类:Endocrinology
Q115 / 122
大类:Medicine
小类:Oncology
Q148 / 360
大类:Medicine
小类:Cancer Research
Q144 / 210

期刊简介Endocrine-Related Cancer is an official flagship journal of the Society for Endocrinology and is endorsed by the European Society of Endocrinology, the United Kingdom and Ireland Neuroendocrine Society, and the Japanese Hormones and Cancer Society.

Endocrine-Related Cancer provides a unique international forum for the publication of high quality original articles describing novel, cutting edge basic laboratory, translational and clinical investigations of human health and disease focusing on endocrine neoplasias and hormone-dependent cancers; and for the publication of authoritative review articles in these topics.

Endocrine neoplasias include adrenal cortex, breast, multiple endocrine neoplasia, neuroendocrine tumours, ovary, prostate, paraganglioma, parathyroid, pheochromocytoma pituitary, testes, thyroid and hormone-dependent cancers. Neoplasias affecting metabolism and energy production such as bladder, bone, kidney, lung, and head and neck, are also considered.
期刊官方网站http://erc.endocrinology-journals.org/
期刊投稿网址http://www.endocrinology-journals.org/site/misc/submit-online.xhtml
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ENDOCRINE-RELATED CANCER的语言要求,还能让ENDOCRINE-RELATED CANCER编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ENDOCRINE-RELATED CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式BIOSCIENTIFICA LTD, EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL, ENGLAND, BS324JT
出版商BioScientifica Ltd.
涉及的研究方向医学-内分泌学与代谢
出版国家或地区ENGLAND
出版语言English
出版周期Quarterly
出版年份1994
年文章数 98点击查看年文章数趋势图
Gold OA文章占比14.29%
研究类文章占比:
文章 ÷(文章 + 综述)
64.29%
WOS期刊SCI分区
2021-2022年最新版
WOS分区等级:1区

按学科分区
ENDOCRINOLOGY & METABOLISM Q1Q1Q1
ONCOLOGY Q3Q2Q4
中科院《国际期刊预警
名单(试行)》名单
2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2021年01月发布的2020版:不在预警名单中
中科院SCI期刊分区
2022年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区4区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
1区2区2区
ONCOLOGY
肿瘤学
4区3区2区
中科院SCI期刊分区
2021年12月基础版
大类学科小类学科Top期刊综述期刊
医学 1区2区2区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
2区3区2区
ONCOLOGY
肿瘤学
3区4区3区
中科院SCI期刊分区
2021年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区3区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
2区1区2区
ONCOLOGY
肿瘤学
4区3区3区
中科院SCI期刊分区
2020年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区3区
ENDOCRINOLOGY & METABOLISM
内分泌学与代谢
2区1区2区
ONCOLOGY
肿瘤学
2区1区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1351-0088%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
一般
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在ENDOCRINE-RELATED CANCER顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 ENDOCRINE-RELATED CANCER期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 ENDOCRINE-RELATED CANCER中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
ENDOCRINE-RELATED CANCER上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Nature Reviews Endocrinology11644.90
    Cell Metabolism21940.70
    ENDOCRINE REVIEWS25740.00
    DIABETES CARE32827.70
    METABOLISM-CLINICAL AND EXPERIMENTAL12216.50
    JOURNAL OF PINEAL RESEARCH11323.00
    Obesity Reviews13714.30
    TRENDS IN ENDOCRINOLOGY AND METABOLISM14617.90
    DIABETOLOGIA20716.60
    DIABETES30412.30
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE524790
    Frontiers in Pharmacology369597
    BIOMEDICINE & PHARMACOTHERAPY357906
    JOURNAL OF ETHNOPHARMACOLOGY329405
    Frontiers in Immunology326182
    Frontiers in Oncology314125
    Theranostics276438
    Molecular Medicine Reports269389
    International Journal of Nanomedicine267068
    CANCER LETTERS266501
  •  

    ENDOCRINE-RELATED CANCER ENDOCRINE-RELATED CANCER
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ.

    Author: Xekouki P1,2, Lodge EJ1,3, Matschke J4, Santambrogio A1,5, Apps JR6,7, Sharif A8, Jacques TS6,7, Aylwin S2, Prevot V8, Li R9, Flitsch J10, Bornstein SR3,5, Theodoropoulou M11, Andoniadou CL1,5.
    Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):215-225. doi: 10.1530/ERC-18-0330.
        PubMed      DOI
    2.Antitumor effects of anlotinib in thyroid cancer.

    Author: Ruan X1, Shi X2, Dong Q2, Yu Y1, Hou X1, Song X2, Wei X3, Chen L2, Gao M1.
    Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):153-164. doi: 10.1530/ERC-17-0558.
        PubMed      DOI
    3.KLF14 potentiates oxidative adaptation via modulating HO-1 signaling in castrate-resistant prostate cancer.

    Author: Luo XH1, Liu JZ1, Wang B1, Men QL1, Ju YQ1, Yin FY1, Zheng C1, Li W2.
    Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):181-195. doi: 10.1530/ERC-18-0383.
        PubMed      DOI
    4.Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.

    Author: Guan W1, Hu J1,2,3, Yang L4, Tan P4, Tang Z4, West BL5, Bollag G5, Xu H1, Wu L3,6,7,8,9.
    Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):131-140. doi: 10.1530/ERC-18-0284.
        PubMed      DOI
    5.ATM deficiency promotes progression of CRPC by enhancing Warburg effect.

    Author: Xu L1,2, Ma E3, Zeng T2,4, Zhao R5, Tao Y2, Chen X2, Groth J2, Liang C1, Hu H2,6, Huang J2,6,7.
    Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):59-71. doi: 10.1530/ERC-18-0196.
        PubMed      DOI
    6.KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC.

    Author: Wei X1, Cai S2,3, Boohaker RJ2, Fried J2, Li Y4, Hu L5, Pan Y5, Cheng R5, Zhang S1, Tian Y3, Gao M5, Xu B2,6.
    Journal: Endocr Relat Cancer. 2019 Jan 1;26(1):141-151. doi: 10.1530/ERC-18-0193.
        PubMed      DOI
    7.SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer.

    Author: Han F1, Liu WB2, Li JJ3, Zhang MQ4, Yang JT5, Zhang X6, Hao XL7, Yin L8, Mao CY9, Jiang X10, Cao J11, Liu JY12.
    Journal: Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0529.R1. doi: 10.1530/ERC-18-0529. [Epub ahead of print]
        PubMed      DOI
    8.Roles of the HOXA10 gene during castrate-resistant prostate cancer progression.

    Author: Long Z1,2, Li Y2, Gan Y2,3, Zhao D4,5,6, Wang G4,5,6, Xie N2, Lovnicki JM2, Fazli L2, Cao Q7, Chen K4,5,6, Dong X2.
    Journal: Endocr Relat Cancer. 2019 Mar 1;26(3):279-292. doi: 10.1530/ERC-18-0465.
        PubMed      DOI
    9.Targeting autophagy in thyroid cancers.

    Author: Wei WJ1, Hardin H2, Luo QY3.
    Journal: Endocr Relat Cancer. 2019 Jan 1. pii: ERC-18-0502.R1. doi: 10.1530/ERC-18-0502. [Epub ahead of print]
        PubMed      DOI
    10.Exosomes increased angiogenesis in papillary thyroid cancer microenvironment.

    Author: Wu F1, Li F2, Lin X3, Xu F4, Cui R5, Zhong J6, Zhu T7, Shan SK8, Liao XB9, Yuan L10, Mo Z11.
    Journal: Endocr Relat Cancer. 2019 Mar 1. pii: ERC-19-0008.R1. doi: 10.1530/ERC-19-0008. [Epub ahead of print]
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144716.20
    LANCET700115.30
    NEW ENGLAND JOURNAL OF MEDICINE933110.50
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62238.80
    NATURE REVIEWS DRUG DISCOVERY28965.90
    NATURE REVIEWS IMMUNOLOGY35170.80
    Lancet Respiratory Medicine7961.60
    BMJ-British Medical Journal010.20
    BMJ-British Medical Journal010.20
    NATURE MEDICINE49791.90
    同分区等级的其他期刊名称 h-index CiteScore
    JOURNAL OF TRAVEL MEDICINE5115.20
    BEHAVIORAL AND BRAIN SCIENCES1481.50
    Eurosurveillance9022.10
    Emerging Microbes & Infections3119.00
    NUCLEIC ACIDS RESEARCH45228.00
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE714.30
    Annual Review of Nuclear and Particle Science9023.90
    CYTOKINE & GROWTH FACTOR REVIEWS14814.60
    Journal of Extracellular Vesicles027.40
    EMERGING INFECTIOUS DISEASES20213.00


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共1条 (包含回复)

我来分享

    关闭窗口

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2023 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451